Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples